Results 111 to 120 of about 79,696 (205)

Meta-analysis examining phosphodiesterase-5 inhibitors in heart failure with preserved ejection fraction. [PDF]

Proc (Bayl Univ Med Cent), 2022
Adhikari G, Baral N, Rauniyar R, Tse G, Karki S, Abdelazeem B, Gergis K, Savarapu P, Isa S, Sud P, Kunadi A.   +10 more
europepmc   +1 more source

A 10,000-Foot View at Survival and Treatment with Phosphodiesterase-5 Inhibitors in Interstitial Lung Disease Pulmonary Hypertension. [PDF]

Am J Respir Crit Care Med
Shlobin OA, Piccari L.
europepmc   +1 more source

Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med, 2022
Xanthopoulos A, Magouliotis DE, Tryposkiadis K, Zotos PA, Spiliopoulos K, Athanasiou T, Giamouzis G, Skoularigis J, Starling RC, Triposkiadis F.   +9 more
europepmc   +1 more source

Efficacy and Safety of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis. [PDF]

Neuropsychiatr Dis Treat
Saito A, Sakuma K, Iwata N, Kishi T.
europepmc   +1 more source

Contemporary cost-analysis comparison of direct-to-consumer vs. traditional prescriptions of phosphodiesterase-5 inhibitors. [PDF]

Int J Impot Res, 2023
Schneider D, Loeb CA, Brevik A, El-Khatib F, Jenkins LC, Yafi FA.   +5 more
europepmc   +1 more source

Treatment With Phosphodiesterase 5 Inhibitors and Long-Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization. [PDF]

Catheter Cardiovasc Interv
Roy S, Min A, McFalls EO, Perera RA, Salloum FN, Jovin IS.   +5 more
europepmc   +1 more source

Exploring patient preferences regarding the use of combination therapy with endothelin receptor antagonist (ERA) + phosphodiesterase-5 inhibitors (PDE5i). [PDF]

JHLT Open
Kolaitis NA, Kingman M, Wilson M, Rendon GG, Lopez D, Paoli CJ, Rahman M, Martin A, McGarvey N, Lee A, Mirza S, Melendres-Groves L.   +11 more
europepmc   +1 more source

Contribution of sewage to occurrence of phosphodiesterase-5 inhibitors in natural water. [PDF]

Sci Rep, 2021
Hong Y, Lee I, Tae B, Lee W, Pan SY, Snyder SW, Kim H.   +6 more
europepmc   +1 more source

Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study. [PDF]

BMC Pulm Med
Kam THH, Kam KKH, Wong MKL, Yan BPY, Tan G.   +4 more
europepmc   +1 more source

No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study. [PDF]

Brain Commun, 2022
Desai RJ, Mahesri M, Lee SB, Varma VR, Loeffler T, Schilcher I, Gerhard T, Segal JB, Ritchey ME, Horton DB, Kim SC, Schneeweiss S, Thambisetty M.   +12 more
europepmc   +1 more source